Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lab Notes: Teleflex making acquisition valued at up to $300M; Vyant Bio files delayed quarterly report By: Philadelphia Business Journal via Business Journals August 26, 2022 at 10:07 AM EDT A Berwyn biopharm firm dosed the first patient in a late-stage clinical trial testing its lead new drug candidate in patients with Parkinson's disease. Read More >> Related Stocks: Harbor Disruptive Innovation ETF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Lab Notes: Teleflex making acquisition valued at up to $300M; Vyant Bio files delayed quarterly report By: Philadelphia Business Journal via Business Journals August 26, 2022 at 10:07 AM EDT A Berwyn biopharm firm dosed the first patient in a late-stage clinical trial testing its lead new drug candidate in patients with Parkinson's disease. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
